Patient_ID
stringlengths 8
8
| Age
int64 18
89
| Gender
stringclasses 2
values | Weight_kg
float64 50.2
100
| Height_cm
float64 150
200
| Comorbidities
stringclasses 4
values | Previous_Treatments
stringclasses 3
values | Tumor_Histology
stringclasses 4
values | Tumor_Grade
stringclasses 3
values | Tumor_Stage
stringclasses 4
values | Imaging_Modality
stringclasses 3
values | Image_Resolution
stringclasses 2
values | Scan_Type
stringclasses 2
values | Scanner_Manufacturer
stringclasses 3
values | Gross_Tumor_Volume_cm3
float64 1.22
150
| Clinical_Target_Volume_cm3
float64 0.96
200
| Planning_Target_Volume_cm3
float64 1.47
249
| Beam_Arrangements
stringclasses 2
values | Dose_Distributions_Gy
float64 10.2
99.8
| Optimization_Objectives
stringclasses 3
values | Dose_Volume_Histogram
stringlengths 9
9
| Synthetic_Image_Path
stringlengths 41
41
| GTV_Segmentation_Path
stringlengths 45
45
| CTV_Segmentation_Path
stringlengths 45
45
| PTV_Segmentation_Path
stringlengths 45
45
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SIM-0101 | 51 | Female | 64.9 | 171.9 | Cancer History | null | Meningioma | Intermediate | II | PET | Anisotropic | Non-Contrast-Enhanced | Philips | 135.47 | 178.71 | 113.15 | Single | 52.85 | Organ-Sparing | DVH_P0101 | /simulated/path/P0101_synthetic_image.nii | /simulated/path/SIM-0101_GTV_segmentation.nii | /simulated/path/SIM-0101_CTV_segmentation.nii | /simulated/path/SIM-0101_PTV_segmentation.nii |
SIM-0102 | 24 | Female | 94.9 | 181 | Diabetes | null | Metastatic | High | III | CT | Isotropic | Contrast-Enhanced | GE | 67.42 | 86.28 | 160.48 | Multi-Beam | 27.1 | Balanced | DVH_P0102 | /simulated/path/P0102_synthetic_image.nii | /simulated/path/SIM-0102_GTV_segmentation.nii | /simulated/path/SIM-0102_CTV_segmentation.nii | /simulated/path/SIM-0102_PTV_segmentation.nii |
SIM-0103 | 42 | Male | 74.7 | 194.3 | Cardiac Issues | Surgery | Meningioma | Low | II | MRI | Isotropic | Non-Contrast-Enhanced | GE | 96.85 | 28.15 | 74.76 | Multi-Beam | 74.92 | Organ-Sparing | DVH_P0103 | /simulated/path/P0103_synthetic_image.nii | /simulated/path/SIM-0103_GTV_segmentation.nii | /simulated/path/SIM-0103_CTV_segmentation.nii | /simulated/path/SIM-0103_PTV_segmentation.nii |
SIM-0104 | 40 | Male | 71.7 | 170 | Diabetes | Radiotherapy | Meningioma | Intermediate | I | MRI | Isotropic | Non-Contrast-Enhanced | GE | 89.72 | 38.51 | 77.21 | Single | 62.92 | Balanced | DVH_P0104 | /simulated/path/P0104_synthetic_image.nii | /simulated/path/SIM-0104_GTV_segmentation.nii | /simulated/path/SIM-0104_CTV_segmentation.nii | /simulated/path/SIM-0104_PTV_segmentation.nii |
SIM-0105 | 83 | Female | 92 | 184.7 | Cancer History | Radiotherapy | Astrocytoma | Low | IV | MRI | Anisotropic | Contrast-Enhanced | GE | 112.44 | 17.36 | 168.77 | Single | 58.85 | Maximize Tumor Dose | DVH_P0105 | /simulated/path/P0105_synthetic_image.nii | /simulated/path/SIM-0105_GTV_segmentation.nii | /simulated/path/SIM-0105_CTV_segmentation.nii | /simulated/path/SIM-0105_PTV_segmentation.nii |
SIM-0106 | 66 | Male | 52.6 | 186.2 | Cardiac Issues | Chemotherapy | Meningioma | High | II | CT | Anisotropic | Non-Contrast-Enhanced | Philips | 35.41 | 109.95 | 119.85 | Single | 16.44 | Balanced | DVH_P0106 | /simulated/path/P0106_synthetic_image.nii | /simulated/path/SIM-0106_GTV_segmentation.nii | /simulated/path/SIM-0106_CTV_segmentation.nii | /simulated/path/SIM-0106_PTV_segmentation.nii |
SIM-0107 | 65 | Female | 77.6 | 172.2 | Cancer History | Radiotherapy | Meningioma | High | I | PET | Anisotropic | Non-Contrast-Enhanced | Siemens | 85.43 | 28.78 | 165.04 | Single | 90.43 | Maximize Tumor Dose | DVH_P0107 | /simulated/path/P0107_synthetic_image.nii | /simulated/path/SIM-0107_GTV_segmentation.nii | /simulated/path/SIM-0107_CTV_segmentation.nii | /simulated/path/SIM-0107_PTV_segmentation.nii |
SIM-0108 | 88 | Female | 50.8 | 183.4 | Hypertension | null | Meningioma | High | III | CT | Isotropic | Non-Contrast-Enhanced | Philips | 48.26 | 52.8 | 33.33 | Multi-Beam | 96.78 | Maximize Tumor Dose | DVH_P0108 | /simulated/path/P0108_synthetic_image.nii | /simulated/path/SIM-0108_GTV_segmentation.nii | /simulated/path/SIM-0108_CTV_segmentation.nii | /simulated/path/SIM-0108_PTV_segmentation.nii |
SIM-0109 | 83 | Female | 95.6 | 176.8 | null | Radiotherapy | Meningioma | Intermediate | II | CT | Isotropic | Non-Contrast-Enhanced | Siemens | 102.51 | 99.85 | 245.83 | Multi-Beam | 97.78 | Organ-Sparing | DVH_P0109 | /simulated/path/P0109_synthetic_image.nii | /simulated/path/SIM-0109_GTV_segmentation.nii | /simulated/path/SIM-0109_CTV_segmentation.nii | /simulated/path/SIM-0109_PTV_segmentation.nii |
SIM-0110 | 54 | Male | 82.6 | 196.5 | Diabetes | Chemotherapy | Meningioma | Low | I | MRI | Isotropic | Contrast-Enhanced | Siemens | 58.79 | 164.2 | 249.18 | Multi-Beam | 48.48 | Organ-Sparing | DVH_P0110 | /simulated/path/P0110_synthetic_image.nii | /simulated/path/SIM-0110_GTV_segmentation.nii | /simulated/path/SIM-0110_CTV_segmentation.nii | /simulated/path/SIM-0110_PTV_segmentation.nii |
SIM-0111 | 52 | Male | 81.8 | 156.1 | Hypertension | Radiotherapy | Metastatic | Low | III | PET | Isotropic | Non-Contrast-Enhanced | GE | 87.14 | 110.79 | 137.54 | Multi-Beam | 79.46 | Organ-Sparing | DVH_P0111 | /simulated/path/P0111_synthetic_image.nii | /simulated/path/SIM-0111_GTV_segmentation.nii | /simulated/path/SIM-0111_CTV_segmentation.nii | /simulated/path/SIM-0111_PTV_segmentation.nii |
SIM-0112 | 55 | Male | 76.6 | 191 | Cancer History | null | Meningioma | Low | IV | MRI | Isotropic | Non-Contrast-Enhanced | Philips | 120.29 | 176.95 | 131.3 | Multi-Beam | 30.65 | Organ-Sparing | DVH_P0112 | /simulated/path/P0112_synthetic_image.nii | /simulated/path/SIM-0112_GTV_segmentation.nii | /simulated/path/SIM-0112_CTV_segmentation.nii | /simulated/path/SIM-0112_PTV_segmentation.nii |
SIM-0113 | 83 | Female | 61.7 | 162.5 | Cancer History | Chemotherapy | Glioblastoma | Low | IV | CT | Anisotropic | Contrast-Enhanced | GE | 125.87 | 81.3 | 178.41 | Multi-Beam | 74.2 | Balanced | DVH_P0113 | /simulated/path/P0113_synthetic_image.nii | /simulated/path/SIM-0113_GTV_segmentation.nii | /simulated/path/SIM-0113_CTV_segmentation.nii | /simulated/path/SIM-0113_PTV_segmentation.nii |
SIM-0114 | 47 | Male | 69.5 | 176.4 | Hypertension | Surgery | Metastatic | Low | II | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 111.93 | 117.68 | 199.64 | Single | 92.17 | Maximize Tumor Dose | DVH_P0114 | /simulated/path/P0114_synthetic_image.nii | /simulated/path/SIM-0114_GTV_segmentation.nii | /simulated/path/SIM-0114_CTV_segmentation.nii | /simulated/path/SIM-0114_PTV_segmentation.nii |
SIM-0115 | 23 | Female | 60.6 | 179.2 | Diabetes | Surgery | Glioblastoma | High | I | MRI | Anisotropic | Contrast-Enhanced | GE | 101.09 | 100.2 | 207.47 | Multi-Beam | 55.74 | Balanced | DVH_P0115 | /simulated/path/P0115_synthetic_image.nii | /simulated/path/SIM-0115_GTV_segmentation.nii | /simulated/path/SIM-0115_CTV_segmentation.nii | /simulated/path/SIM-0115_PTV_segmentation.nii |
SIM-0116 | 20 | Male | 82.1 | 196.3 | Diabetes | null | Metastatic | Intermediate | I | PET | Isotropic | Contrast-Enhanced | Philips | 58.49 | 105.05 | 179.79 | Single | 64.59 | Maximize Tumor Dose | DVH_P0116 | /simulated/path/P0116_synthetic_image.nii | /simulated/path/SIM-0116_GTV_segmentation.nii | /simulated/path/SIM-0116_CTV_segmentation.nii | /simulated/path/SIM-0116_PTV_segmentation.nii |
SIM-0117 | 60 | Male | 59.4 | 199.7 | Diabetes | Surgery | Metastatic | Low | I | CT | Isotropic | Non-Contrast-Enhanced | GE | 77.67 | 30.6 | 238.02 | Single | 26.62 | Balanced | DVH_P0117 | /simulated/path/P0117_synthetic_image.nii | /simulated/path/SIM-0117_GTV_segmentation.nii | /simulated/path/SIM-0117_CTV_segmentation.nii | /simulated/path/SIM-0117_PTV_segmentation.nii |
SIM-0118 | 41 | Male | 70.1 | 180.6 | null | Chemotherapy | Astrocytoma | Intermediate | I | CT | Isotropic | Contrast-Enhanced | GE | 3.63 | 154.06 | 136.76 | Single | 92.29 | Organ-Sparing | DVH_P0118 | /simulated/path/P0118_synthetic_image.nii | /simulated/path/SIM-0118_GTV_segmentation.nii | /simulated/path/SIM-0118_CTV_segmentation.nii | /simulated/path/SIM-0118_PTV_segmentation.nii |
SIM-0119 | 38 | Male | 93.7 | 170.8 | Hypertension | Radiotherapy | Glioblastoma | Intermediate | IV | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 94.5 | 142.25 | 98.61 | Single | 39.39 | Balanced | DVH_P0119 | /simulated/path/P0119_synthetic_image.nii | /simulated/path/SIM-0119_GTV_segmentation.nii | /simulated/path/SIM-0119_CTV_segmentation.nii | /simulated/path/SIM-0119_PTV_segmentation.nii |
SIM-0120 | 24 | Male | 78.8 | 188.1 | Cancer History | Chemotherapy | Astrocytoma | Low | IV | MRI | Isotropic | Non-Contrast-Enhanced | Philips | 135.36 | 73.77 | 107.29 | Multi-Beam | 63.26 | Balanced | DVH_P0120 | /simulated/path/P0120_synthetic_image.nii | /simulated/path/SIM-0120_GTV_segmentation.nii | /simulated/path/SIM-0120_CTV_segmentation.nii | /simulated/path/SIM-0120_PTV_segmentation.nii |
SIM-0121 | 59 | Female | 95.7 | 192.8 | Cardiac Issues | Radiotherapy | Glioblastoma | High | I | PET | Isotropic | Contrast-Enhanced | GE | 67.15 | 121.67 | 19.46 | Multi-Beam | 46.1 | Maximize Tumor Dose | DVH_P0121 | /simulated/path/P0121_synthetic_image.nii | /simulated/path/SIM-0121_GTV_segmentation.nii | /simulated/path/SIM-0121_CTV_segmentation.nii | /simulated/path/SIM-0121_PTV_segmentation.nii |
SIM-0122 | 52 | Male | 53.9 | 180.6 | Cancer History | Surgery | Meningioma | Intermediate | III | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 112.68 | 54.65 | 248.63 | Multi-Beam | 14.31 | Balanced | DVH_P0122 | /simulated/path/P0122_synthetic_image.nii | /simulated/path/SIM-0122_GTV_segmentation.nii | /simulated/path/SIM-0122_CTV_segmentation.nii | /simulated/path/SIM-0122_PTV_segmentation.nii |
SIM-0123 | 67 | Female | 94.4 | 151.7 | Diabetes | Surgery | Astrocytoma | High | III | PET | Isotropic | Contrast-Enhanced | GE | 31.66 | 24.49 | 88.3 | Single | 54.38 | Balanced | DVH_P0123 | /simulated/path/P0123_synthetic_image.nii | /simulated/path/SIM-0123_GTV_segmentation.nii | /simulated/path/SIM-0123_CTV_segmentation.nii | /simulated/path/SIM-0123_PTV_segmentation.nii |
SIM-0124 | 23 | Male | 90.8 | 163.2 | Diabetes | Surgery | Metastatic | Intermediate | I | PET | Isotropic | Non-Contrast-Enhanced | Philips | 45.28 | 66.12 | 180.14 | Single | 84.47 | Organ-Sparing | DVH_P0124 | /simulated/path/P0124_synthetic_image.nii | /simulated/path/SIM-0124_GTV_segmentation.nii | /simulated/path/SIM-0124_CTV_segmentation.nii | /simulated/path/SIM-0124_PTV_segmentation.nii |
SIM-0125 | 85 | Female | 78.5 | 187.1 | Hypertension | Chemotherapy | Meningioma | Intermediate | IV | CT | Isotropic | Contrast-Enhanced | Siemens | 28.67 | 65.06 | 177.1 | Single | 98.89 | Organ-Sparing | DVH_P0125 | /simulated/path/P0125_synthetic_image.nii | /simulated/path/SIM-0125_GTV_segmentation.nii | /simulated/path/SIM-0125_CTV_segmentation.nii | /simulated/path/SIM-0125_PTV_segmentation.nii |
SIM-0126 | 75 | Female | 57.7 | 164.1 | Cancer History | null | Metastatic | Low | I | MRI | Anisotropic | Non-Contrast-Enhanced | GE | 21.61 | 114.77 | 39.04 | Multi-Beam | 63.39 | Balanced | DVH_P0126 | /simulated/path/P0126_synthetic_image.nii | /simulated/path/SIM-0126_GTV_segmentation.nii | /simulated/path/SIM-0126_CTV_segmentation.nii | /simulated/path/SIM-0126_PTV_segmentation.nii |
SIM-0127 | 80 | Female | 51.3 | 156.7 | Diabetes | Surgery | Meningioma | Intermediate | II | CT | Isotropic | Non-Contrast-Enhanced | Philips | 63.89 | 38.23 | 54.54 | Multi-Beam | 87.15 | Balanced | DVH_P0127 | /simulated/path/P0127_synthetic_image.nii | /simulated/path/SIM-0127_GTV_segmentation.nii | /simulated/path/SIM-0127_CTV_segmentation.nii | /simulated/path/SIM-0127_PTV_segmentation.nii |
SIM-0128 | 54 | Male | 92.3 | 167.2 | Cancer History | Surgery | Astrocytoma | High | III | CT | Anisotropic | Contrast-Enhanced | Siemens | 34.51 | 177.62 | 34.77 | Multi-Beam | 52.35 | Balanced | DVH_P0128 | /simulated/path/P0128_synthetic_image.nii | /simulated/path/SIM-0128_GTV_segmentation.nii | /simulated/path/SIM-0128_CTV_segmentation.nii | /simulated/path/SIM-0128_PTV_segmentation.nii |
SIM-0129 | 42 | Male | 93.7 | 186.3 | Hypertension | Radiotherapy | Glioblastoma | Low | IV | MRI | Isotropic | Contrast-Enhanced | Siemens | 35.44 | 191.74 | 73.35 | Multi-Beam | 45.31 | Organ-Sparing | DVH_P0129 | /simulated/path/P0129_synthetic_image.nii | /simulated/path/SIM-0129_GTV_segmentation.nii | /simulated/path/SIM-0129_CTV_segmentation.nii | /simulated/path/SIM-0129_PTV_segmentation.nii |
SIM-0130 | 27 | Female | 67.2 | 154.3 | Diabetes | Radiotherapy | Astrocytoma | High | I | CT | Anisotropic | Contrast-Enhanced | Siemens | 110.75 | 67.38 | 24.43 | Single | 44.38 | Maximize Tumor Dose | DVH_P0130 | /simulated/path/P0130_synthetic_image.nii | /simulated/path/SIM-0130_GTV_segmentation.nii | /simulated/path/SIM-0130_CTV_segmentation.nii | /simulated/path/SIM-0130_PTV_segmentation.nii |
SIM-0131 | 52 | Female | 69.6 | 179.9 | Cardiac Issues | Surgery | Meningioma | Low | II | CT | Isotropic | Non-Contrast-Enhanced | Siemens | 27.49 | 31.24 | 196.09 | Single | 94.86 | Balanced | DVH_P0131 | /simulated/path/P0131_synthetic_image.nii | /simulated/path/SIM-0131_GTV_segmentation.nii | /simulated/path/SIM-0131_CTV_segmentation.nii | /simulated/path/SIM-0131_PTV_segmentation.nii |
SIM-0132 | 81 | Male | 93.4 | 187.6 | null | null | Metastatic | Intermediate | I | MRI | Anisotropic | Non-Contrast-Enhanced | Siemens | 4.7 | 48.43 | 183.6 | Multi-Beam | 28.43 | Balanced | DVH_P0132 | /simulated/path/P0132_synthetic_image.nii | /simulated/path/SIM-0132_GTV_segmentation.nii | /simulated/path/SIM-0132_CTV_segmentation.nii | /simulated/path/SIM-0132_PTV_segmentation.nii |
SIM-0133 | 20 | Male | 96.7 | 183.1 | Hypertension | null | Meningioma | Low | IV | MRI | Anisotropic | Non-Contrast-Enhanced | GE | 56.83 | 154.91 | 69.74 | Single | 51.93 | Organ-Sparing | DVH_P0133 | /simulated/path/P0133_synthetic_image.nii | /simulated/path/SIM-0133_GTV_segmentation.nii | /simulated/path/SIM-0133_CTV_segmentation.nii | /simulated/path/SIM-0133_PTV_segmentation.nii |
SIM-0134 | 34 | Male | 70.5 | 197.9 | Diabetes | Surgery | Astrocytoma | Intermediate | IV | PET | Isotropic | Contrast-Enhanced | GE | 132.02 | 43.74 | 228.78 | Multi-Beam | 13.49 | Organ-Sparing | DVH_P0134 | /simulated/path/P0134_synthetic_image.nii | /simulated/path/SIM-0134_GTV_segmentation.nii | /simulated/path/SIM-0134_CTV_segmentation.nii | /simulated/path/SIM-0134_PTV_segmentation.nii |
SIM-0135 | 29 | Male | 97.6 | 167.5 | Diabetes | Radiotherapy | Glioblastoma | High | III | PET | Isotropic | Contrast-Enhanced | Siemens | 33.88 | 141.61 | 226.51 | Multi-Beam | 96.3 | Balanced | DVH_P0135 | /simulated/path/P0135_synthetic_image.nii | /simulated/path/SIM-0135_GTV_segmentation.nii | /simulated/path/SIM-0135_CTV_segmentation.nii | /simulated/path/SIM-0135_PTV_segmentation.nii |
SIM-0136 | 39 | Female | 71.3 | 194.8 | Cardiac Issues | Surgery | Metastatic | Intermediate | I | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 73.82 | 137.33 | 89.61 | Single | 16.97 | Balanced | DVH_P0136 | /simulated/path/P0136_synthetic_image.nii | /simulated/path/SIM-0136_GTV_segmentation.nii | /simulated/path/SIM-0136_CTV_segmentation.nii | /simulated/path/SIM-0136_PTV_segmentation.nii |
SIM-0137 | 83 | Female | 75.1 | 170.8 | null | Radiotherapy | Meningioma | Intermediate | I | CT | Anisotropic | Contrast-Enhanced | Philips | 44.13 | 48.01 | 47.98 | Single | 48.61 | Organ-Sparing | DVH_P0137 | /simulated/path/P0137_synthetic_image.nii | /simulated/path/SIM-0137_GTV_segmentation.nii | /simulated/path/SIM-0137_CTV_segmentation.nii | /simulated/path/SIM-0137_PTV_segmentation.nii |
SIM-0138 | 19 | Female | 64.9 | 185.8 | Cancer History | Chemotherapy | Meningioma | Intermediate | IV | CT | Anisotropic | Non-Contrast-Enhanced | Siemens | 52 | 56.76 | 210.11 | Single | 97.09 | Organ-Sparing | DVH_P0138 | /simulated/path/P0138_synthetic_image.nii | /simulated/path/SIM-0138_GTV_segmentation.nii | /simulated/path/SIM-0138_CTV_segmentation.nii | /simulated/path/SIM-0138_PTV_segmentation.nii |
SIM-0139 | 38 | Male | 89.9 | 182.8 | Cancer History | Chemotherapy | Metastatic | High | II | PET | Isotropic | Contrast-Enhanced | Siemens | 79.18 | 145.47 | 103.61 | Single | 86.13 | Organ-Sparing | DVH_P0139 | /simulated/path/P0139_synthetic_image.nii | /simulated/path/SIM-0139_GTV_segmentation.nii | /simulated/path/SIM-0139_CTV_segmentation.nii | /simulated/path/SIM-0139_PTV_segmentation.nii |
SIM-0140 | 75 | Female | 89.8 | 195.5 | Cancer History | Radiotherapy | Glioblastoma | Low | IV | PET | Anisotropic | Non-Contrast-Enhanced | Philips | 82.46 | 27.71 | 175.63 | Single | 12.93 | Organ-Sparing | DVH_P0140 | /simulated/path/P0140_synthetic_image.nii | /simulated/path/SIM-0140_GTV_segmentation.nii | /simulated/path/SIM-0140_CTV_segmentation.nii | /simulated/path/SIM-0140_PTV_segmentation.nii |
SIM-0141 | 49 | Female | 95.1 | 189.4 | Hypertension | Chemotherapy | Meningioma | High | III | CT | Anisotropic | Contrast-Enhanced | Philips | 49.19 | 197.3 | 166.01 | Multi-Beam | 33.93 | Maximize Tumor Dose | DVH_P0141 | /simulated/path/P0141_synthetic_image.nii | /simulated/path/SIM-0141_GTV_segmentation.nii | /simulated/path/SIM-0141_CTV_segmentation.nii | /simulated/path/SIM-0141_PTV_segmentation.nii |
SIM-0142 | 26 | Male | 54.9 | 165.3 | Hypertension | Surgery | Metastatic | High | II | MRI | Anisotropic | Non-Contrast-Enhanced | GE | 101.41 | 194.94 | 148.47 | Single | 78.84 | Balanced | DVH_P0142 | /simulated/path/P0142_synthetic_image.nii | /simulated/path/SIM-0142_GTV_segmentation.nii | /simulated/path/SIM-0142_CTV_segmentation.nii | /simulated/path/SIM-0142_PTV_segmentation.nii |
SIM-0143 | 80 | Female | 71 | 154.1 | null | Surgery | Metastatic | High | IV | PET | Isotropic | Non-Contrast-Enhanced | Philips | 127.52 | 19.86 | 169.08 | Multi-Beam | 97.12 | Organ-Sparing | DVH_P0143 | /simulated/path/P0143_synthetic_image.nii | /simulated/path/SIM-0143_GTV_segmentation.nii | /simulated/path/SIM-0143_CTV_segmentation.nii | /simulated/path/SIM-0143_PTV_segmentation.nii |
SIM-0144 | 63 | Female | 57.4 | 176.6 | null | null | Meningioma | Low | I | CT | Isotropic | Non-Contrast-Enhanced | GE | 61.44 | 119.84 | 76.48 | Multi-Beam | 12.96 | Maximize Tumor Dose | DVH_P0144 | /simulated/path/P0144_synthetic_image.nii | /simulated/path/SIM-0144_GTV_segmentation.nii | /simulated/path/SIM-0144_CTV_segmentation.nii | /simulated/path/SIM-0144_PTV_segmentation.nii |
SIM-0145 | 64 | Male | 80.3 | 195.1 | Cardiac Issues | Radiotherapy | Meningioma | Intermediate | I | MRI | Anisotropic | Non-Contrast-Enhanced | GE | 25.91 | 160.07 | 76.05 | Single | 84.98 | Balanced | DVH_P0145 | /simulated/path/P0145_synthetic_image.nii | /simulated/path/SIM-0145_GTV_segmentation.nii | /simulated/path/SIM-0145_CTV_segmentation.nii | /simulated/path/SIM-0145_PTV_segmentation.nii |
SIM-0146 | 88 | Female | 77.6 | 199.8 | null | Chemotherapy | Astrocytoma | Low | III | CT | Isotropic | Contrast-Enhanced | GE | 131.48 | 78.88 | 212.23 | Multi-Beam | 58.08 | Balanced | DVH_P0146 | /simulated/path/P0146_synthetic_image.nii | /simulated/path/SIM-0146_GTV_segmentation.nii | /simulated/path/SIM-0146_CTV_segmentation.nii | /simulated/path/SIM-0146_PTV_segmentation.nii |
SIM-0147 | 50 | Female | 54.3 | 167.5 | Cardiac Issues | Radiotherapy | Metastatic | Intermediate | II | CT | Anisotropic | Non-Contrast-Enhanced | Siemens | 135.83 | 97.12 | 220.42 | Multi-Beam | 98.5 | Organ-Sparing | DVH_P0147 | /simulated/path/P0147_synthetic_image.nii | /simulated/path/SIM-0147_GTV_segmentation.nii | /simulated/path/SIM-0147_CTV_segmentation.nii | /simulated/path/SIM-0147_PTV_segmentation.nii |
SIM-0148 | 45 | Female | 77.5 | 190.4 | null | Radiotherapy | Glioblastoma | High | II | CT | Anisotropic | Non-Contrast-Enhanced | GE | 13.31 | 88.5 | 99.98 | Multi-Beam | 19.15 | Balanced | DVH_P0148 | /simulated/path/P0148_synthetic_image.nii | /simulated/path/SIM-0148_GTV_segmentation.nii | /simulated/path/SIM-0148_CTV_segmentation.nii | /simulated/path/SIM-0148_PTV_segmentation.nii |
SIM-0149 | 61 | Male | 91.9 | 166.6 | null | Radiotherapy | Metastatic | Low | IV | CT | Anisotropic | Non-Contrast-Enhanced | GE | 27.26 | 78.66 | 163.71 | Single | 67.13 | Balanced | DVH_P0149 | /simulated/path/P0149_synthetic_image.nii | /simulated/path/SIM-0149_GTV_segmentation.nii | /simulated/path/SIM-0149_CTV_segmentation.nii | /simulated/path/SIM-0149_PTV_segmentation.nii |
SIM-0150 | 73 | Male | 62.5 | 177.4 | null | Radiotherapy | Metastatic | High | II | PET | Isotropic | Contrast-Enhanced | Siemens | 121.8 | 88.61 | 116.08 | Single | 23.64 | Organ-Sparing | DVH_P0150 | /simulated/path/P0150_synthetic_image.nii | /simulated/path/SIM-0150_GTV_segmentation.nii | /simulated/path/SIM-0150_CTV_segmentation.nii | /simulated/path/SIM-0150_PTV_segmentation.nii |
SIM-0151 | 51 | Male | 99.2 | 198.5 | null | null | Astrocytoma | High | II | CT | Isotropic | Non-Contrast-Enhanced | Philips | 75.61 | 71.02 | 22.95 | Single | 64.64 | Maximize Tumor Dose | DVH_P0151 | /simulated/path/P0151_synthetic_image.nii | /simulated/path/SIM-0151_GTV_segmentation.nii | /simulated/path/SIM-0151_CTV_segmentation.nii | /simulated/path/SIM-0151_PTV_segmentation.nii |
SIM-0152 | 41 | Male | 78.8 | 177 | Diabetes | Chemotherapy | Astrocytoma | Intermediate | II | CT | Isotropic | Non-Contrast-Enhanced | GE | 66.92 | 144.64 | 112.33 | Multi-Beam | 68.38 | Organ-Sparing | DVH_P0152 | /simulated/path/P0152_synthetic_image.nii | /simulated/path/SIM-0152_GTV_segmentation.nii | /simulated/path/SIM-0152_CTV_segmentation.nii | /simulated/path/SIM-0152_PTV_segmentation.nii |
SIM-0153 | 25 | Male | 94.9 | 176.1 | Cardiac Issues | Surgery | Astrocytoma | High | IV | PET | Isotropic | Contrast-Enhanced | Philips | 95.04 | 70.87 | 206.91 | Single | 80.2 | Balanced | DVH_P0153 | /simulated/path/P0153_synthetic_image.nii | /simulated/path/SIM-0153_GTV_segmentation.nii | /simulated/path/SIM-0153_CTV_segmentation.nii | /simulated/path/SIM-0153_PTV_segmentation.nii |
SIM-0154 | 22 | Female | 87.9 | 150.5 | Cardiac Issues | Radiotherapy | Glioblastoma | Intermediate | IV | MRI | Anisotropic | Contrast-Enhanced | Siemens | 31.45 | 74.71 | 147.05 | Single | 32.96 | Balanced | DVH_P0154 | /simulated/path/P0154_synthetic_image.nii | /simulated/path/SIM-0154_GTV_segmentation.nii | /simulated/path/SIM-0154_CTV_segmentation.nii | /simulated/path/SIM-0154_PTV_segmentation.nii |
SIM-0155 | 73 | Male | 93.2 | 171.7 | Diabetes | Radiotherapy | Glioblastoma | High | II | PET | Anisotropic | Contrast-Enhanced | GE | 17.93 | 133.93 | 183.93 | Single | 88.73 | Balanced | DVH_P0155 | /simulated/path/P0155_synthetic_image.nii | /simulated/path/SIM-0155_GTV_segmentation.nii | /simulated/path/SIM-0155_CTV_segmentation.nii | /simulated/path/SIM-0155_PTV_segmentation.nii |
SIM-0156 | 68 | Female | 79 | 181 | Cardiac Issues | Surgery | Meningioma | Intermediate | II | PET | Isotropic | Non-Contrast-Enhanced | Philips | 2.75 | 178.87 | 145.57 | Single | 20.56 | Maximize Tumor Dose | DVH_P0156 | /simulated/path/P0156_synthetic_image.nii | /simulated/path/SIM-0156_GTV_segmentation.nii | /simulated/path/SIM-0156_CTV_segmentation.nii | /simulated/path/SIM-0156_PTV_segmentation.nii |
SIM-0157 | 33 | Male | 89.5 | 151.7 | null | null | Glioblastoma | Intermediate | I | CT | Isotropic | Contrast-Enhanced | GE | 119.59 | 95.97 | 140.13 | Multi-Beam | 50.85 | Maximize Tumor Dose | DVH_P0157 | /simulated/path/P0157_synthetic_image.nii | /simulated/path/SIM-0157_GTV_segmentation.nii | /simulated/path/SIM-0157_CTV_segmentation.nii | /simulated/path/SIM-0157_PTV_segmentation.nii |
SIM-0158 | 57 | Female | 63.9 | 153.4 | Diabetes | Chemotherapy | Metastatic | Intermediate | I | MRI | Anisotropic | Contrast-Enhanced | GE | 117.17 | 130.34 | 89.19 | Multi-Beam | 36.98 | Organ-Sparing | DVH_P0158 | /simulated/path/P0158_synthetic_image.nii | /simulated/path/SIM-0158_GTV_segmentation.nii | /simulated/path/SIM-0158_CTV_segmentation.nii | /simulated/path/SIM-0158_PTV_segmentation.nii |
SIM-0159 | 53 | Male | 80.2 | 193.5 | Cancer History | null | Glioblastoma | High | IV | PET | Isotropic | Contrast-Enhanced | GE | 48.68 | 89.8 | 182.24 | Multi-Beam | 74.3 | Organ-Sparing | DVH_P0159 | /simulated/path/P0159_synthetic_image.nii | /simulated/path/SIM-0159_GTV_segmentation.nii | /simulated/path/SIM-0159_CTV_segmentation.nii | /simulated/path/SIM-0159_PTV_segmentation.nii |
SIM-0160 | 82 | Male | 87.9 | 194.4 | null | Radiotherapy | Metastatic | High | III | MRI | Isotropic | Non-Contrast-Enhanced | GE | 33.02 | 168.37 | 102.02 | Multi-Beam | 33.45 | Balanced | DVH_P0160 | /simulated/path/P0160_synthetic_image.nii | /simulated/path/SIM-0160_GTV_segmentation.nii | /simulated/path/SIM-0160_CTV_segmentation.nii | /simulated/path/SIM-0160_PTV_segmentation.nii |
SIM-0161 | 25 | Female | 61.6 | 195.6 | Diabetes | Chemotherapy | Glioblastoma | Low | I | MRI | Isotropic | Contrast-Enhanced | GE | 131.73 | 70.62 | 223.49 | Single | 63.56 | Maximize Tumor Dose | DVH_P0161 | /simulated/path/P0161_synthetic_image.nii | /simulated/path/SIM-0161_GTV_segmentation.nii | /simulated/path/SIM-0161_CTV_segmentation.nii | /simulated/path/SIM-0161_PTV_segmentation.nii |
SIM-0162 | 82 | Female | 77.3 | 159.6 | Cardiac Issues | null | Metastatic | Low | IV | MRI | Anisotropic | Non-Contrast-Enhanced | Siemens | 98.92 | 166.77 | 148.87 | Single | 23.76 | Balanced | DVH_P0162 | /simulated/path/P0162_synthetic_image.nii | /simulated/path/SIM-0162_GTV_segmentation.nii | /simulated/path/SIM-0162_CTV_segmentation.nii | /simulated/path/SIM-0162_PTV_segmentation.nii |
SIM-0163 | 74 | Female | 60.9 | 190.2 | Hypertension | null | Metastatic | Low | I | PET | Anisotropic | Contrast-Enhanced | Philips | 135.12 | 97.31 | 195.59 | Single | 72.52 | Organ-Sparing | DVH_P0163 | /simulated/path/P0163_synthetic_image.nii | /simulated/path/SIM-0163_GTV_segmentation.nii | /simulated/path/SIM-0163_CTV_segmentation.nii | /simulated/path/SIM-0163_PTV_segmentation.nii |
SIM-0164 | 61 | Female | 71.2 | 189.5 | Cardiac Issues | Radiotherapy | Meningioma | Low | II | PET | Isotropic | Non-Contrast-Enhanced | Siemens | 43.82 | 32.64 | 186.82 | Single | 29.44 | Maximize Tumor Dose | DVH_P0164 | /simulated/path/P0164_synthetic_image.nii | /simulated/path/SIM-0164_GTV_segmentation.nii | /simulated/path/SIM-0164_CTV_segmentation.nii | /simulated/path/SIM-0164_PTV_segmentation.nii |
SIM-0165 | 76 | Female | 81.9 | 165.3 | null | Chemotherapy | Glioblastoma | Intermediate | III | CT | Isotropic | Non-Contrast-Enhanced | GE | 125.17 | 45.28 | 113.68 | Multi-Beam | 58.88 | Balanced | DVH_P0165 | /simulated/path/P0165_synthetic_image.nii | /simulated/path/SIM-0165_GTV_segmentation.nii | /simulated/path/SIM-0165_CTV_segmentation.nii | /simulated/path/SIM-0165_PTV_segmentation.nii |
SIM-0166 | 88 | Female | 74.9 | 186.8 | Hypertension | null | Metastatic | Intermediate | I | PET | Anisotropic | Contrast-Enhanced | Siemens | 101.26 | 187.01 | 151.92 | Single | 40.52 | Maximize Tumor Dose | DVH_P0166 | /simulated/path/P0166_synthetic_image.nii | /simulated/path/SIM-0166_GTV_segmentation.nii | /simulated/path/SIM-0166_CTV_segmentation.nii | /simulated/path/SIM-0166_PTV_segmentation.nii |
SIM-0167 | 65 | Male | 54 | 188.1 | Diabetes | Surgery | Glioblastoma | Low | I | PET | Isotropic | Contrast-Enhanced | Philips | 132.06 | 152.34 | 30.38 | Single | 99.16 | Organ-Sparing | DVH_P0167 | /simulated/path/P0167_synthetic_image.nii | /simulated/path/SIM-0167_GTV_segmentation.nii | /simulated/path/SIM-0167_CTV_segmentation.nii | /simulated/path/SIM-0167_PTV_segmentation.nii |
SIM-0168 | 51 | Female | 97.3 | 193.9 | null | Chemotherapy | Astrocytoma | High | IV | PET | Anisotropic | Contrast-Enhanced | GE | 97.93 | 31.69 | 96.96 | Single | 41.18 | Organ-Sparing | DVH_P0168 | /simulated/path/P0168_synthetic_image.nii | /simulated/path/SIM-0168_GTV_segmentation.nii | /simulated/path/SIM-0168_CTV_segmentation.nii | /simulated/path/SIM-0168_PTV_segmentation.nii |
SIM-0169 | 64 | Female | 95.3 | 157.3 | Hypertension | null | Metastatic | Intermediate | IV | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 147.37 | 75.95 | 120.31 | Multi-Beam | 58.04 | Maximize Tumor Dose | DVH_P0169 | /simulated/path/P0169_synthetic_image.nii | /simulated/path/SIM-0169_GTV_segmentation.nii | /simulated/path/SIM-0169_CTV_segmentation.nii | /simulated/path/SIM-0169_PTV_segmentation.nii |
SIM-0170 | 70 | Female | 65.7 | 160.5 | Diabetes | Chemotherapy | Glioblastoma | Low | IV | MRI | Isotropic | Contrast-Enhanced | GE | 104.43 | 146.37 | 169.08 | Multi-Beam | 84.16 | Maximize Tumor Dose | DVH_P0170 | /simulated/path/P0170_synthetic_image.nii | /simulated/path/SIM-0170_GTV_segmentation.nii | /simulated/path/SIM-0170_CTV_segmentation.nii | /simulated/path/SIM-0170_PTV_segmentation.nii |
SIM-0171 | 64 | Male | 53.6 | 169.5 | Diabetes | Chemotherapy | Astrocytoma | Low | III | CT | Anisotropic | Non-Contrast-Enhanced | Siemens | 46.26 | 108.29 | 44.95 | Multi-Beam | 42.39 | Organ-Sparing | DVH_P0171 | /simulated/path/P0171_synthetic_image.nii | /simulated/path/SIM-0171_GTV_segmentation.nii | /simulated/path/SIM-0171_CTV_segmentation.nii | /simulated/path/SIM-0171_PTV_segmentation.nii |
SIM-0172 | 55 | Female | 57 | 153 | Cancer History | Radiotherapy | Glioblastoma | Low | II | CT | Isotropic | Contrast-Enhanced | Siemens | 90.12 | 108.22 | 62.75 | Multi-Beam | 98.46 | Maximize Tumor Dose | DVH_P0172 | /simulated/path/P0172_synthetic_image.nii | /simulated/path/SIM-0172_GTV_segmentation.nii | /simulated/path/SIM-0172_CTV_segmentation.nii | /simulated/path/SIM-0172_PTV_segmentation.nii |
SIM-0173 | 26 | Female | 73.7 | 150.5 | Cardiac Issues | Chemotherapy | Meningioma | Intermediate | III | PET | Anisotropic | Non-Contrast-Enhanced | GE | 78.04 | 94.37 | 118.43 | Multi-Beam | 11.19 | Organ-Sparing | DVH_P0173 | /simulated/path/P0173_synthetic_image.nii | /simulated/path/SIM-0173_GTV_segmentation.nii | /simulated/path/SIM-0173_CTV_segmentation.nii | /simulated/path/SIM-0173_PTV_segmentation.nii |
SIM-0174 | 70 | Female | 95.9 | 166.8 | Cancer History | Chemotherapy | Metastatic | Intermediate | IV | PET | Isotropic | Contrast-Enhanced | Siemens | 90.43 | 196.5 | 168.25 | Single | 13.84 | Balanced | DVH_P0174 | /simulated/path/P0174_synthetic_image.nii | /simulated/path/SIM-0174_GTV_segmentation.nii | /simulated/path/SIM-0174_CTV_segmentation.nii | /simulated/path/SIM-0174_PTV_segmentation.nii |
SIM-0175 | 68 | Male | 52.4 | 173.3 | Diabetes | Surgery | Glioblastoma | High | I | CT | Anisotropic | Non-Contrast-Enhanced | Philips | 90.48 | 3.02 | 208.18 | Multi-Beam | 15.79 | Organ-Sparing | DVH_P0175 | /simulated/path/P0175_synthetic_image.nii | /simulated/path/SIM-0175_GTV_segmentation.nii | /simulated/path/SIM-0175_CTV_segmentation.nii | /simulated/path/SIM-0175_PTV_segmentation.nii |
SIM-0176 | 41 | Male | 78.8 | 179.9 | Hypertension | Radiotherapy | Meningioma | Intermediate | II | MRI | Anisotropic | Contrast-Enhanced | GE | 30.27 | 76.47 | 181.58 | Multi-Beam | 67.75 | Organ-Sparing | DVH_P0176 | /simulated/path/P0176_synthetic_image.nii | /simulated/path/SIM-0176_GTV_segmentation.nii | /simulated/path/SIM-0176_CTV_segmentation.nii | /simulated/path/SIM-0176_PTV_segmentation.nii |
SIM-0177 | 37 | Male | 51.4 | 196.1 | Cardiac Issues | null | Meningioma | Intermediate | I | PET | Isotropic | Contrast-Enhanced | Siemens | 26.48 | 186.47 | 33.03 | Multi-Beam | 52.67 | Organ-Sparing | DVH_P0177 | /simulated/path/P0177_synthetic_image.nii | /simulated/path/SIM-0177_GTV_segmentation.nii | /simulated/path/SIM-0177_CTV_segmentation.nii | /simulated/path/SIM-0177_PTV_segmentation.nii |
SIM-0178 | 18 | Female | 92.4 | 163.1 | Cardiac Issues | null | Astrocytoma | Intermediate | IV | PET | Isotropic | Contrast-Enhanced | GE | 114.06 | 50.35 | 69.96 | Multi-Beam | 39.11 | Maximize Tumor Dose | DVH_P0178 | /simulated/path/P0178_synthetic_image.nii | /simulated/path/SIM-0178_GTV_segmentation.nii | /simulated/path/SIM-0178_CTV_segmentation.nii | /simulated/path/SIM-0178_PTV_segmentation.nii |
SIM-0179 | 52 | Female | 52.6 | 182 | Diabetes | Chemotherapy | Glioblastoma | High | II | CT | Anisotropic | Non-Contrast-Enhanced | GE | 2.26 | 77.06 | 222.4 | Multi-Beam | 44.46 | Organ-Sparing | DVH_P0179 | /simulated/path/P0179_synthetic_image.nii | /simulated/path/SIM-0179_GTV_segmentation.nii | /simulated/path/SIM-0179_CTV_segmentation.nii | /simulated/path/SIM-0179_PTV_segmentation.nii |
SIM-0180 | 39 | Female | 63.6 | 191.2 | Hypertension | Surgery | Metastatic | High | I | PET | Isotropic | Non-Contrast-Enhanced | Siemens | 55.81 | 142.37 | 177.54 | Single | 12.37 | Organ-Sparing | DVH_P0180 | /simulated/path/P0180_synthetic_image.nii | /simulated/path/SIM-0180_GTV_segmentation.nii | /simulated/path/SIM-0180_CTV_segmentation.nii | /simulated/path/SIM-0180_PTV_segmentation.nii |
SIM-0181 | 69 | Female | 83.8 | 191 | null | Chemotherapy | Meningioma | High | III | CT | Anisotropic | Contrast-Enhanced | Siemens | 116.51 | 29.19 | 65.8 | Single | 26.47 | Balanced | DVH_P0181 | /simulated/path/P0181_synthetic_image.nii | /simulated/path/SIM-0181_GTV_segmentation.nii | /simulated/path/SIM-0181_CTV_segmentation.nii | /simulated/path/SIM-0181_PTV_segmentation.nii |
SIM-0182 | 41 | Female | 96.3 | 198.5 | Diabetes | null | Metastatic | Intermediate | IV | PET | Isotropic | Non-Contrast-Enhanced | Siemens | 64.56 | 33.19 | 143.56 | Multi-Beam | 47.17 | Maximize Tumor Dose | DVH_P0182 | /simulated/path/P0182_synthetic_image.nii | /simulated/path/SIM-0182_GTV_segmentation.nii | /simulated/path/SIM-0182_CTV_segmentation.nii | /simulated/path/SIM-0182_PTV_segmentation.nii |
SIM-0183 | 57 | Female | 54.6 | 186.9 | Cancer History | Surgery | Glioblastoma | Low | III | MRI | Isotropic | Non-Contrast-Enhanced | GE | 93.17 | 11.84 | 134.62 | Single | 34.82 | Organ-Sparing | DVH_P0183 | /simulated/path/P0183_synthetic_image.nii | /simulated/path/SIM-0183_GTV_segmentation.nii | /simulated/path/SIM-0183_CTV_segmentation.nii | /simulated/path/SIM-0183_PTV_segmentation.nii |
SIM-0184 | 73 | Male | 68.2 | 173.7 | Cancer History | Radiotherapy | Metastatic | High | III | MRI | Isotropic | Non-Contrast-Enhanced | GE | 53.31 | 129.63 | 123.74 | Single | 27.14 | Balanced | DVH_P0184 | /simulated/path/P0184_synthetic_image.nii | /simulated/path/SIM-0184_GTV_segmentation.nii | /simulated/path/SIM-0184_CTV_segmentation.nii | /simulated/path/SIM-0184_PTV_segmentation.nii |
SIM-0185 | 42 | Female | 81.6 | 198.4 | Hypertension | Chemotherapy | Meningioma | Intermediate | III | PET | Isotropic | Contrast-Enhanced | GE | 12 | 86.4 | 160.07 | Multi-Beam | 78.37 | Maximize Tumor Dose | DVH_P0185 | /simulated/path/P0185_synthetic_image.nii | /simulated/path/SIM-0185_GTV_segmentation.nii | /simulated/path/SIM-0185_CTV_segmentation.nii | /simulated/path/SIM-0185_PTV_segmentation.nii |
SIM-0186 | 27 | Male | 87.7 | 195.5 | Cardiac Issues | Chemotherapy | Metastatic | Low | IV | CT | Isotropic | Contrast-Enhanced | GE | 113.39 | 144.54 | 138.36 | Multi-Beam | 45.76 | Organ-Sparing | DVH_P0186 | /simulated/path/P0186_synthetic_image.nii | /simulated/path/SIM-0186_GTV_segmentation.nii | /simulated/path/SIM-0186_CTV_segmentation.nii | /simulated/path/SIM-0186_PTV_segmentation.nii |
SIM-0187 | 50 | Male | 54.8 | 168.2 | Cancer History | Radiotherapy | Astrocytoma | High | III | PET | Anisotropic | Non-Contrast-Enhanced | Philips | 82.38 | 86.88 | 60.99 | Multi-Beam | 59.57 | Maximize Tumor Dose | DVH_P0187 | /simulated/path/P0187_synthetic_image.nii | /simulated/path/SIM-0187_GTV_segmentation.nii | /simulated/path/SIM-0187_CTV_segmentation.nii | /simulated/path/SIM-0187_PTV_segmentation.nii |
SIM-0188 | 73 | Female | 51.9 | 177.6 | null | Surgery | Metastatic | Intermediate | III | CT | Isotropic | Non-Contrast-Enhanced | GE | 67.78 | 41.54 | 134.83 | Multi-Beam | 35.4 | Maximize Tumor Dose | DVH_P0188 | /simulated/path/P0188_synthetic_image.nii | /simulated/path/SIM-0188_GTV_segmentation.nii | /simulated/path/SIM-0188_CTV_segmentation.nii | /simulated/path/SIM-0188_PTV_segmentation.nii |
SIM-0189 | 70 | Male | 95.8 | 150.6 | Diabetes | Chemotherapy | Astrocytoma | High | I | MRI | Isotropic | Contrast-Enhanced | Philips | 29.63 | 67.89 | 208.79 | Multi-Beam | 31.11 | Balanced | DVH_P0189 | /simulated/path/P0189_synthetic_image.nii | /simulated/path/SIM-0189_GTV_segmentation.nii | /simulated/path/SIM-0189_CTV_segmentation.nii | /simulated/path/SIM-0189_PTV_segmentation.nii |
SIM-0190 | 55 | Female | 71.3 | 152.7 | null | Chemotherapy | Meningioma | High | II | MRI | Anisotropic | Contrast-Enhanced | Siemens | 79.12 | 116.92 | 89.74 | Multi-Beam | 28.47 | Maximize Tumor Dose | DVH_P0190 | /simulated/path/P0190_synthetic_image.nii | /simulated/path/SIM-0190_GTV_segmentation.nii | /simulated/path/SIM-0190_CTV_segmentation.nii | /simulated/path/SIM-0190_PTV_segmentation.nii |
SIM-0191 | 37 | Female | 83.1 | 158.3 | Cancer History | Surgery | Astrocytoma | Low | I | CT | Isotropic | Contrast-Enhanced | GE | 110.23 | 175.13 | 40.39 | Multi-Beam | 69.74 | Balanced | DVH_P0191 | /simulated/path/P0191_synthetic_image.nii | /simulated/path/SIM-0191_GTV_segmentation.nii | /simulated/path/SIM-0191_CTV_segmentation.nii | /simulated/path/SIM-0191_PTV_segmentation.nii |
SIM-0192 | 65 | Male | 93.3 | 176.4 | Cardiac Issues | Chemotherapy | Glioblastoma | Intermediate | III | CT | Isotropic | Contrast-Enhanced | Siemens | 68.73 | 57.14 | 192.75 | Multi-Beam | 21.76 | Balanced | DVH_P0192 | /simulated/path/P0192_synthetic_image.nii | /simulated/path/SIM-0192_GTV_segmentation.nii | /simulated/path/SIM-0192_CTV_segmentation.nii | /simulated/path/SIM-0192_PTV_segmentation.nii |
SIM-0193 | 85 | Female | 63.6 | 170.4 | Cancer History | Radiotherapy | Meningioma | Low | III | MRI | Isotropic | Contrast-Enhanced | Philips | 83.2 | 103.52 | 15.84 | Multi-Beam | 70 | Balanced | DVH_P0193 | /simulated/path/P0193_synthetic_image.nii | /simulated/path/SIM-0193_GTV_segmentation.nii | /simulated/path/SIM-0193_CTV_segmentation.nii | /simulated/path/SIM-0193_PTV_segmentation.nii |
SIM-0194 | 75 | Male | 85.8 | 179.6 | Cancer History | Radiotherapy | Glioblastoma | Low | II | PET | Anisotropic | Contrast-Enhanced | Philips | 119.05 | 75.74 | 24.95 | Single | 97.22 | Maximize Tumor Dose | DVH_P0194 | /simulated/path/P0194_synthetic_image.nii | /simulated/path/SIM-0194_GTV_segmentation.nii | /simulated/path/SIM-0194_CTV_segmentation.nii | /simulated/path/SIM-0194_PTV_segmentation.nii |
SIM-0195 | 41 | Female | 78.7 | 185 | Cardiac Issues | Radiotherapy | Astrocytoma | High | I | PET | Anisotropic | Non-Contrast-Enhanced | GE | 119.1 | 113.15 | 89.01 | Multi-Beam | 73.71 | Balanced | DVH_P0195 | /simulated/path/P0195_synthetic_image.nii | /simulated/path/SIM-0195_GTV_segmentation.nii | /simulated/path/SIM-0195_CTV_segmentation.nii | /simulated/path/SIM-0195_PTV_segmentation.nii |
SIM-0196 | 83 | Female | 64.9 | 185.9 | Cardiac Issues | Chemotherapy | Metastatic | Intermediate | I | PET | Isotropic | Non-Contrast-Enhanced | Philips | 14.04 | 71.18 | 203.8 | Multi-Beam | 21.93 | Organ-Sparing | DVH_P0196 | /simulated/path/P0196_synthetic_image.nii | /simulated/path/SIM-0196_GTV_segmentation.nii | /simulated/path/SIM-0196_CTV_segmentation.nii | /simulated/path/SIM-0196_PTV_segmentation.nii |
SIM-0197 | 88 | Female | 75.2 | 193 | Diabetes | Radiotherapy | Metastatic | Intermediate | I | PET | Anisotropic | Contrast-Enhanced | GE | 40.32 | 166.18 | 12.55 | Single | 27.35 | Maximize Tumor Dose | DVH_P0197 | /simulated/path/P0197_synthetic_image.nii | /simulated/path/SIM-0197_GTV_segmentation.nii | /simulated/path/SIM-0197_CTV_segmentation.nii | /simulated/path/SIM-0197_PTV_segmentation.nii |
SIM-0198 | 72 | Female | 67.8 | 183.8 | Cancer History | Surgery | Glioblastoma | Low | IV | CT | Isotropic | Non-Contrast-Enhanced | GE | 99.9 | 44.39 | 183.56 | Single | 21.49 | Maximize Tumor Dose | DVH_P0198 | /simulated/path/P0198_synthetic_image.nii | /simulated/path/SIM-0198_GTV_segmentation.nii | /simulated/path/SIM-0198_CTV_segmentation.nii | /simulated/path/SIM-0198_PTV_segmentation.nii |
SIM-0199 | 71 | Male | 61.8 | 188.4 | null | null | Meningioma | Low | III | PET | Isotropic | Contrast-Enhanced | Siemens | 132.38 | 124.08 | 74.63 | Multi-Beam | 68.91 | Organ-Sparing | DVH_P0199 | /simulated/path/P0199_synthetic_image.nii | /simulated/path/SIM-0199_GTV_segmentation.nii | /simulated/path/SIM-0199_CTV_segmentation.nii | /simulated/path/SIM-0199_PTV_segmentation.nii |
SIM-0200 | 20 | Female | 68 | 152.8 | null | Surgery | Metastatic | High | IV | CT | Anisotropic | Non-Contrast-Enhanced | GE | 26.81 | 63.7 | 148.5 | Multi-Beam | 39.24 | Maximize Tumor Dose | DVH_P0200 | /simulated/path/P0200_synthetic_image.nii | /simulated/path/SIM-0200_GTV_segmentation.nii | /simulated/path/SIM-0200_CTV_segmentation.nii | /simulated/path/SIM-0200_PTV_segmentation.nii |